NEW DRUGS IN ONCOLOGY
Stampa
Enrollment year
2017/2018
Academic year
2019/2020
Regulations
DM270
Academic discipline
BIO/14 (PHARMACOLOGY)
Department
DEPARTMENT OF DRUGS SCIENCES
Course
PHARMACY
Curriculum
PERCORSO COMUNE
Year of study
Period
2nd semester (02/03/2020 - 19/06/2020)
ECTS
3
Lesson hours
24 lesson hours
Language
Italian
Activity type
WRITTEN TEST
Teacher
AMADIO MARIALAURA (titolare) - 3 ECTS
Prerequisites
=
Learning outcomes
To study in depth the novel pharmacological therapies in oncology.
Course contents
The development of novel effective chemotherapeutic drugs requires the knowledge of the main principles relative to
molecular and cellular pharmacology, allowing to find out appropriate therapeutic targets, that are molecules or pathways
relevant for the etiopathogenesis of tumors.
Biology of tumors, preclinical and clinical research for drug discovery and development; protein kinases; membrane
receptors and transduction signals; intracellular kinases and cell cycles-related enzymes; apoptosis; main novel targeted
therapies; drugs targeting angiogenesis.
Teaching methods
The course is based on lectures provided by the instructor. No practical exams. No in itinere tests.
Reccomended or required readings
The main text is represented by didactic slides provided by the teacher.
Assessment methods
Final written exam at the end of the lessons.
The examination consists of both multiple choice tests and open questions.
Multiple choice test: mandatory choice of only one answer among 4-5 provided for each question (value for each correct answer: 2 points).
Open questions on representative drugs/targets treated during teaching sessions (maximum grade: 8 points). Knowledge of the general context and main features of a given therapeutic target and/or drug, will be required. The use of the appropriate language will be also evaluated.
If the students answer correctly to both multiple choice tests and open questions will get the excellence (31).
Further information
Final written exam at the end of the lessons.
The examination consists of both multiple choice tests and open questions.
Multiple choice test: mandatory choice of only one answer among 4-5 provided for each question (value for each correct answer: 2 points).
Open questions on representative drugs/targets treated during teaching sessions (maximum grade: 8 points). Knowledge of the general context and main features of a given therapeutic target and/or drug, will be required. The use of the appropriate language will be also evaluated.
If the students answer correctly to both multiple choice tests and open questions will get the excellence (31).
Sustainable development goals - Agenda 2030